Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients

NCT00034255 is registered in ClinicalTrials.gov with GMP Endotherapeutics as lead sponsor.

NCT NCT00034255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00034255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients
Lead sponsor
GMP Endotherapeutics
Phase
Phase 1/2
Overall status
Completed
Start date
December 31, 2001
Completion date
Not reported
Enrollment
62
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 1, diabetes mellitus, type 2